Ignite Creation Date:
2024-05-06 @ 7:39 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06085755
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-14
First Post:
2023-09-10
Brief Title:
Trastuzumab DeruxtecanT-DXd and Afatinib Combination in HER2-low Advanced Gastric Cancer
Sponsor:
Organization:
Samsung Medical Center